WuXi AppTec
46
54M
36
1.92
7
0.22
7
- Areas of investment
Summary
WuXi AppTec appeared to be the Corporate Investor, which was created in 2000. The main department of described Corporate Investor is located in the Shanghai. The venture was found in Asia in China.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hua Medicine, DNAnexus, Schrodinger. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Care, Real Time.
The fund was created by Ge Li, John J. Baldwin, Zhaohui Zhang. The overall number of key employees were 2.
Opposing the other organizations, this WuXi AppTec works on 20 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2018. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. Considering the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the WuXi AppTec, startups are often financed by Venrock, WuXi Healthcare Ventures, First Round Capital. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Sequoia Capital China, Watson Fund. In the next rounds fund is usually obtained by Invus, WuXi NextCODE, WuXi Healthcare Ventures.
Investments analytics
Analytics
- Total investments
- 46
- Lead investments
- 7
- Exits
- 7
- Rounds per year
- 1.92
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (37)
- Pharmaceutical (24)
- Health Care (21)
- Medical (12)
- Artificial Intelligence (8) Show 30 more
- Investments by region
-
- China (20)
- United States (20)
- United Kingdom (2)
- Indonesia (1)
- Israel (1) Show 2 more
- Peak activity year
- 2021
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 79M
- Group Appearance index
- 0.98
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.46
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Stemirna | 03 Jun 2021 | Biotechnology, Medical, Pharmaceutical | Late Stage Venture | 185M | Beijing, Dongcheng District, China |
| TruTag Technologies | 16 Jun 2014 | Health Diagnostics, Pharmaceutical, Advanced Materials | Early Stage Venture | 16M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.